EUVIMEDEUVIMED entdecken
Crossref

Pioglitazone and metformin attenuate hemophilic arthropathy progression via peroxisome proliferator–activated receptor signaling pathway activation

Yu Zhou, Yan Shen, Shu-Xian Yao, Da-Wei Wang, Zhu Chen, Sai-Juan Chen

Journal of Thrombosis and Haemostasis · 2026-08 · 24 (8) · 2801-2813

DOI: 10.1016/j.jtha.2026.04.032 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Thrombosis and Haemostasis, 2026-08. Verfasst von Yu Zhou und 5 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin H…. Hauptthemen laut MEDLINE: Metformin, Hemophilia A, Pioglitazone, PPAR gamma. Die Arbeit nennt 17 Literaturangaben. Gefördert von: Double First Class University Plan, National Natural Science Foundation of China, Overseas Expertise Introduction Project for Discipline Innovation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MetforminHemophilia APioglitazonePPAR gammaHemarthrosisJointsAnimalsSignal TransductionDisease Models, AnimalMalePPAR-gamma AgonistsDisease ProgressionRatsHumans

Stichwörter der Autor:innen

hemarthrosishemophilia Ametforminperoxisome proliferator–activated receptorspioglitazone

Substanzen

MetforminPioglitazonePPAR gammaPPAR-gamma AgonistsPPAR gamma, rat

Autor:innen und Institutionen

  • Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, C…
  • Research Center for Experimental Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Förderung

  • Double First Class University Plan
  • National Natural Science Foundation of China
  • Overseas Expertise Introduction Project for Discipline Innovation
  • Shanghai Municipal Health Commission
  • Ministry of Education of the People's Republic of China

Zitieren

APA

Zhou, Y., Shen, Y., Yao, S. X., Wang, D. W., Chen, Z., & Chen, S. J. (2026). Pioglitazone and metformin attenuate hemophilic arthropathy progression via peroxisome proliferator–activated receptor signaling pathway activation. Journal of Thrombosis and Haemostasis, 24(8), 2801-2813. https://doi.org/10.1016/j.jtha.2026.04.032

Vancouver

Zhou Y, Shen Y, Yao SX, Wang DW, Chen Z, Chen SJ. Pioglitazone and metformin attenuate hemophilic arthropathy progression via peroxisome proliferator–activated receptor signaling pathway activation. Journal of Thrombosis and Haemostasis. 2026;24(8):2801-2813. doi:10.1016/j.jtha.2026.04.032

BibTeX
@article{Zhou2026,
  author = {Zhou, Yu and Shen, Yan and Yao, Shu-Xian and Wang, Da-Wei and Chen, Zhu and Chen, Sai-Juan},
  title = {Pioglitazone and metformin attenuate hemophilic arthropathy progression via peroxisome proliferator–activated receptor signaling pathway activation},
  journal = {Journal of Thrombosis and Haemostasis},
  year = {2026},
  volume = {24},
  number = {8},
  pages = {2801--2813},
  doi = {10.1016/j.jtha.2026.04.032}
}
Kostenlos starten →